scPharmaceuticals (SCPH) News and press releases

Dow Up 150 Points; Gold Jumps Over 2%

23 Mar 23

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P 500, also rose, gaining, 0.67% to 3,963.50.

12 Health Care Stocks Moving In Thursday's Intraday Session

23 Mar 23

Movers

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

23 Mar 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs

23 Mar 23

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500, also rose, gaining, 1.70% to 4,004.07.

KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday

23 Mar 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

HC Wainwright & Co. Reiterates Buy on scPharmaceuticals, Maintains $18 Price Target

23 Mar 23

News, Price Target, Reiteration, Analyst Ratings

HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price target.

scPharmaceuticals Q4 EPS $(0.27) Beats $(0.39) Estimate

22 Mar 23

Earnings, News

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.39) by 30.77 percent. This is unchanged from the same period last year.

Earnings Scheduled For March 22, 2023

22 Mar 23

Earnings

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.

Earnings Preview For scPharmaceuticals

21 Mar 23

Earnings

12 Health Care Stocks Moving In Monday's After-Market Session

27 Feb 23

Movers

scPharmaceuticals Announces Launch And Commercial Availability Of FUROSCIX

21 Feb 23

Biotech, News, FDA, General

scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs,

12 Health Care Stocks Moving In Friday's After-Market Session

17 Feb 23

Movers

ScPharmaceuticals Announces Co Is Targeting February 20, 2023 As The Date For Commercial Availability Of FUROSCIX

30 Jan 23

Biotech, News, General

scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today

What 4 Analyst Ratings Have To Say About scPharmaceuticals

27 Jan 23

Analyst Ratings

SVB Leerink Maintains Outperform on scPharmaceuticals, Raises Price Target to $13

27 Jan 23

News, Price Target, Analyst Ratings

SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $12 to $13.

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

22 Mar 23

Earnings, Press Releases

Announced launch and commercial availability of FUROSCIX® (furosemide injection), the first and only self-administered, subcutaneous loop diuretic for the at-home treatment of congestion in chronic heart failure

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22

15 Mar 23

Earnings, News, Press Releases

Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and

scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection)

21 Feb 23

Health Care, Press Releases

BURLINGTON, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies,

scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update

30 Jan 23

Press Releases, General

BURLINGTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies,